EDN1 |
EDN1: Endothelin-1 precursor |
EDN3 |
EDN3: Endothelin-3 precursor |
3.077 |
Evidence |
|
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
CIB1 |
CIB1, CIB, KIP, PRKDCIP: Calcium and integrin-binding protein 1 |
3.077 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
3.077 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
3.077 |
Evidence |
|
XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
3.077 |
Evidence |
|
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
CENPA |
CENPA: Histone H3-like centromeric protein A |
3.077 |
Evidence |
|
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
3.077 |
Evidence |
|
HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
3.077 |
Evidence |
|
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
3.077 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
MARK2 |
IPI00718858 |
3.077 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
3.077 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
GAB2 |
IPI00186990 |
3.077 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
IRS1 |
IRS1: Insulin receptor substrate 1 |
3.077 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
3.077 |
Evidence |
|
A2M |
A2M, FWP007: Alpha-2-macroglobulin precursor |
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
3.077 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
EMD |
EMD, EDMD, STA: Emerin |
3.077 |
Evidence |
|
GFAP |
GFAP: Glial fibrillary acidic protein |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
3.077 |
Evidence |
|
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
3.077 |
Evidence |
|
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
3.077 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
F5 |
F5: Coagulation factor V precursor |
3.077 |
Evidence |
|
IRS1 |
IRS1: Insulin receptor substrate 1 |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
3.077 |
Evidence |
|
BATF |
BATF: Basic leucine zipper transcriptional factor ATF-like |
PCSK9 |
PCSK9, NARC1, PSEC0052: Proprotein convertase subtilisin/kexin type 9 precursor |
3.072 |
Evidence |
|
PSEN2 |
PSEN2, AD4, PS2, PSNL2, STM2: Presenilin-2 |
C20orf18 |
IPI00010266 |
3.072 |
Evidence |
|
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
LMO6 |
LMO6: LIM domain only protein 6 |
KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
3.072 |
Evidence |
|